Substrate induction of osteogenesis from marrow-derived mesenchymal precursors

被引:35
作者
Cool, SM
Nurcombe, V
机构
[1] Inst Mol & Cell Biol, Lab Stem Cells & Tissue Repair, Singapore 138637, Singapore
[2] Natl Univ Singapore, Dept Orthopaed Surg, Singapore 117597, Singapore
关键词
D O I
10.1089/scd.2005.14.632
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Therapeutic modalities aimed at bone regeneration are increasingly employing extracellular matrix (ECM) constituents to control bone marrow progenitor cell (BMPC) commitment, growth, and differentiation. However, the precise role these ECM elements play during stem cell differentiation remains unclear. (See also Salaszynk et al., Stem Cells Dev 14(6): 608-620, 2005; and Schwartz et al., Stem Cells Dev. 14(6), 643-655, 2005, both in this issue.) Because bone formation ultimately begins with the recruitment and commitment of BMPCs into the osteogenic lineage, factors that enhance this process are clearly therapeutic targets. We hypothesized that BMPC attachment, proliferation, and osteogenic differentiation would be potentiated when cultured on ECM proteins normally found in the bone niche. To examine this, we cultured murine BMPCs on laminin-1, fibronectin, and collagen type-1 substrates for up to 14 days and assessed their homogeneity, attachment, proliferation, and expression of the specific bone lineage markers RUNX2, collagen-1, alkaline phosphatase, and osteocalcin. We found that freshly harvested mBMPCs contain a mixed population of progenitor cells and that the mesenchymal pool can be enriched by adherent culture in the presence of leucine methyl ester. Furthermore, mBMPCs attached to laminin, fibronectin, and collagen-1 with varying affinity up to 3 h (fibronectin >= collagen > laminin), after which time no difference could be detected. Despite this, growth was unaffected; cells thereafter proliferated equally well on all substrates up to confluence (7 days). Notably, commitment to the osteoblast lineage (RUNX2) increased up to 14 days for cells cultured on the various substrates, yet no difference was observed at day 14 in the expression of collagen-1, alkaline phosphatase, or osteocalcin. We conclude that mBMPC differentiation down the osteoblastic lineage is time-dependent in osteogenic culture and that attachment to ECM matrices potentiates lineage commitment rather than growth.
引用
收藏
页码:632 / 642
页数:11
相关论文
共 47 条
  • [1] Osteoblast adhesion on biomaterials
    Anselme, K
    [J]. BIOMATERIALS, 2000, 21 (07) : 667 - 681
  • [2] Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO
  • [3] 2-F
  • [4] MESENCHYMAL STEM-CELLS IN IN BONE-DEVELOPMENT, BONE REPAIR, AND SKELETAL REGENERATION THERAPY
    BRUDER, SP
    FINK, DJ
    CAPLAN, AI
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, 56 (03) : 283 - 294
  • [5] Biomaterial developments for bone tissue engineering
    Burg, KJL
    Porter, S
    Kellam, JF
    [J]. BIOMATERIALS, 2000, 21 (23) : 2347 - 2359
  • [6] MESENCHYMAL STEM-CELLS
    CAPLAN, AI
    [J]. JOURNAL OF ORTHOPAEDIC RESEARCH, 1991, 9 (05) : 641 - 650
  • [7] DIFFERENTIATION OF HUMAN BONE-MARROW OSTEOGENIC STROMAL CELLS IN VITRO - INDUCTION OF THE OSTEOBLAST PHENOTYPE BY DEXAMETHASONE
    CHENG, SL
    YANG, JW
    RIFAS, L
    ZHANG, SF
    AVIOLI, LV
    [J]. ENDOCRINOLOGY, 1994, 134 (01) : 277 - 286
  • [8] Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation
    Ducy, P
    Zhang, R
    Geoffroy, V
    Ridall, AL
    Karsenty, G
    [J]. CELL, 1997, 89 (05) : 747 - 754
  • [9] Ducy P, 2000, DEV DYNAM, V219, P461, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1074>3.0.CO
  • [10] 2-C